Meeting KDOQI guideline goals at hemodialysis initiation and survival during the first year

Clinical Journal of the American Society of Nephrology

Volumn 5, Issue 9, 2010, Pages 1574-1581

  Slinin, Yelena ^a,b   Guo, Haifeng ^c   Gilbertson, David T ^c   Mau, Lih Wen ^c   Ensrud, Kristine ^a,b   Rector, Thomas ^a,b   Collins, Allan J ^b,c   Ishani, Areef ^a,b,c  

^a VA MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; HEMOGLOBIN;

ADULT; ALBUMIN BLOOD LEVEL; ARTERIOVENOUS FISTULA; ARTICLE; EVIDENCE BASED PRACTICE; FEMALE; GRAFT DYSFUNCTION; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN BLOOD LEVEL; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NATIONAL KIDNEY FOUNDATION KIDNEY DISEASE OUTCOMES QUALITY INITIATIVE GUIDELINE; PRACTICE GUIDELINE; PREDICTOR VARIABLE; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; RISK; SURVIVAL;

AGED; ARTERIOVENOUS SHUNT, SURGICAL; BIOLOGICAL MARKERS; CHI-SQUARE DISTRIBUTION; FEMALE; GUIDELINE ADHERENCE; HEMOGLOBINS; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MIDDLE AGED; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES AS TOPIC; PROPORTIONAL HAZARDS MODELS; RENAL DIALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SERUM ALBUMIN; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 77957304999     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.01320210     Document Type: Article

References (28)

1. U.S. Renal Data System: USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States, 2009 ed, Bethesda MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2009
2. Gilbertson DT, Liu J, Xue JL, Louis TA, Solid CA, Ebben JP, Collins AJ: Projecting the number of patients with end-stage renal disease in the United States to the year 2015. J Am Soc Nephrol 16: 3736-3741, 2005 (Pubitemid 46211296)
3. National Kidney Foundation: NKF K/DOQI Guidelines: Clinical Practice Guidelines and Clinical Practice Recommendations. 2006. Available at http://www.kidney.org/professionals/Kdoqi/guideline-upHD-PD-VA/va-guide1.htm. Accessed May 12, 2010
4. Rocco MV, Frankenfield DL, Hopson SD, McClellan WM: Relationship between clinical performance measures and outcomes among patients receiving long-term hemodialysis. Ann Intern Med 145: 512-519, 2006 (Pubitemid 46780954)
5. Plantinga LC, Fink NE, Jaar BG, Sadler JH, Levin NW, Coresh J, Klag MJ, Powe NR: Attainment of clinical performance targets and improvement in clinical outcomes and resource use in hemodialysis care: A prospective cohort study. BMC Health Serv Res 7: 5, 2007 (Pubitemid 46169625)
6. Tentori F, Hunt WC, Rohrscheib M, Zhu M, Stidley CA, Servilla K, Miskulin D, Meyer KB, Bedrick EJ, Johnson HK, Zager PG: Which targets in clinical practice guidelines are associated with improved survival in a large dialysis organization? J Am Soc Nephrol 18: 2377-2384, 2007 (Pubitemid 47203853)
7. Rocco MV, Yan G, Gassman J, Lewis JB, Ornt D, Weiss B, Levey AS: Comparison of causes of death using HEMO Study and HCFA end-stage renal disease death notification classification systems. The National Institutes of Health-funded hemodialysis. Health Care Financing Administration. Am J Kidney Dis 39: 146-153, 2002
8. Lee T, Barker J, Allon M: Associations with predialysis vascular access management. Am J Kidney Dis 43: 1008-1013, 2004 (Pubitemid 38691495)
9. Ethier J, Mendelssohn DC, Elder SJ, Hasegawa T, Akizawa T, Akiba T, Canaud BJ, Pisoni RL: Vascular access use and outcomes: An international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant 23: 3219-3226, 2008
10. Marcus RJ, Marcus DA, Sureshkumar KK, Hussain SM, McGill RL: Gender differences in vascular access in hemodialysis patients in the United States: Developing strategies for improving access outcome. Gend Med 4: 193-204, 2007
11. Obrador GT, Ruthazer R, Arora P, Kausz AT, Pereira BJ: Prevalence of and factors associated with suboptimal care before initiation of dialysis in the United States. J Am Soc Nephrol 10: 1793-1800, 1999 (Pubitemid 29364679)
12. Beutler E, Waalen J: The definition of anemia: What is the lower limit of normal of the blood hemoglobin concentration? Blood 107: 1747-1750, 2006 (Pubitemid 43289347)
13. Ward MM: Laboratory abnormalities at the onset of treatment of end-stage renal disease: Are there racial or socioeconomic disparities in care? Arch Intern Med 167: 1083-1091, 2007
14. Ishani A, Guo H, Arneson TJ, Gilbertson DT, Mau LW, Li S, Dunning S, Collins AJ: Possible effects of the new Medicare reimbursement policy on African Americans with ESRD. J Am Soc Nephrol 20: 1607-1613, 2009
15. Beutler E, West C: Hematologic differences between African-Americans and whites: The roles of iron deficiency and alpha-thalassemia on hemoglobin levels and mean corpuscular volume. Blood 106: 740-745, 2005
16. Sehgal AR: Impact of quality improvement efforts on race and sex disparities in hemodialysis. JAMA 289: 996-1000, 2003
17. Fiscella K, Franks P, Gold MR, Clancy CM: Inequality in quality: Addressing socioeconomic, racial, and ethnic disparities in health care. JAMA 283: 2579-2584, 2000 (Pubitemid 30324204)
18. Reddan D, Klassen P, Frankenfield DL, Szczech L, Schwab S, Coladonato J, Rocco M, Lowrie EG, Owen WF Jr: National profile of practice patterns for hemodialysis vascular access in the United States. J Am Soc Nephrol 13: 2117-2124, 2002 (Pubitemid 34790789)
19. Bradbury BD, Fissell RB, Albert JM, Anthony MS, Critchlow CW, Pisoni RL, Port FK, Gillespie BW: Predictors of early mortality among incident US hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Clin J Am Soc Nephrol 2: 89-99, 2007
20. McClellan WM, Frankenfield DL, Frederick PR, Helgerson SD, Wish JB, Sugarman JR: Improving the care of ESRD patients: A success story. Health Care Financ Rev 24: 89-100, 2003 (Pubitemid 37264939)
21. McClellan WM, Wasse H, McClellan AC, Kipp A, Waller LA, Rocco MV: Treatment center and geographic variability in pre-ESRD care associate with increased mortality. J Am Soc Nephrol 20: 1078-1085, 2009
22. Arora P, Obrador GT, Ruthazer R, Kausz AT, Meyer KB, Jenuleson CS, Pereira BJ: Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center. J Am Soc Nephrol 10: 1281-1286, 1999 (Pubitemid 29246993)
23. Kinchen KS, Sadler J, Fink N, Brookmeyer R, Klag MJ, Levey AS, Powe NR: The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med 137: 479-486, 2002 (Pubitemid 35024618)
24. Kazmi WH, Obrador GT, Khan SS, Pereira BJ, Kausz AT: Late nephrology referral and mortality among patients with end-stage renal disease: A propensity score analysis. Nephrol Dial Transplant 19: 1808-1814, 2004
25. Winkelmayer WC, Owen WF Jr, Levin R, Avorn J: A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol 14: 486-492, 2003 (Pubitemid 36150874)
26. Pfeffer MA, Burdmann EA, Chen CY, Cooper ME, de ZD, Eckardt KU, Feyzi JM, Ivanovich P, Kewalramani R, Levey AS, Lewis EF, McGill JB, McMurray JJ, Parfrey P, Parving HH, Remuzzi G, Singh AK, Solomon SD, Toto R: A trial of darbepoetin alfa in type 2 diabetes and chronic kidney disease. N Engl J Med 361: 2019-2032, 2009
27. Drueke TB, Locatelli F, Clyne N, Eckardt KU, Macdougall IC, Tsakiris D, Burger HU, Scherhag A: Normalization of hemoglobin level in patients with chronic kidney disease and anemia. N Engl J Med 355: 2071-2084, 2006 (Pubitemid 44749316)
28. Singh AK, Szczech L, Tang KL, Barnhart H, Sapp S, Wolfson M, Reddan D: Correction of anemia with epoetin alfa in chronic kidney disease. N Engl J Med 355: 2085-2098, 2006 (Pubitemid 44749317)